# A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.

> **NCT00711880** · PHASE3 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 125 (actual)

## Conditions studied

- Pain
- Peripheral Neuropathy

## Interventions

- **DRUG:** Sativex®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00711880
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2004-03
- **Final completion:** 2004-03
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2023-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00711880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00711880, "A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00711880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*